In any deal, emotions can run high. But letting them take over could cost you more than your cool—it could cost you the deal itself.
We’re seeing real dollars, factory builds, acquisitions, and strategic shifts from the largest OEMs to mid-sized and even startup players.
Due diligence helps ensure the future of a partnership looks bright for all stakeholders. Part 1 of our Today’s Medical Developments Magazine article, we tell you what you need to know about this part of the acquisition process.
Thank you to all who have been part of our journey! We look forward to continuing to support business owners in the healthcare space around the world.
These transactions – where companies spin off, sell, or reallocate parts of their business – reshape portfolios, redefine priorities, and unlock value across the healthcare ecosystem.
Congratulations to our partners at Johnson & Johnson MedTech / DePuy Synthes and Ortoma AB on delivering this innovative technology to the market for the benefit of patient outcomes and all stakeholders involved.
MedWorld Advisors serves as advisor to Vascular Technology, Inc, a medical device company specializing in innovative surgical devices and single-use consumables for the operating room, in their sale to middle market PE firm JLL Partners.
Explore how MedTech companies can build long-term intrinsic value through market strategy, financial health, culture, and innovation.
As shown in past economic cycles, M&A will serve as an avenue to adapt to these changes and increase sustainability for businesses and customers alike.
Among the many dynamics impacting the industry is resilience—the key to success of any size OEM or supplier.